ILMN

Illumina
D

ILMN

Arincen70/100B

Illumina revenue 1999–2026

Illumina's revenue in Q3 FY2026, the three months to 27 September 2026, was 1.13B USD, up 4.2% on the same quarter a year before. Illumina's revenue over the last twelve months was 4.54B USD, up 5.9% on the twelve months before. In fiscal year 2025 it was 4.34B USD, down 0.8% on the year before.

Last updated 12 Nov 2026 · Next report 4 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM27 Sept 20264.54B+5.93%3.10B895.00M
FY202528 Dec 20254.34B-0.78%2.89B850.00M
FY202429 Dec 20244.37B-2.93%2.86B-1.22B
FY202331 Dec 20234.50B-1.75%2.74B-1.16B
FY20221 Jan 20234.58B+1.28%2.97B-4.40B
FY20212 Jan 20224.53B+39.73%3.15B762.00M
FY20203 Jan 20213.24B-8.58%2.20B656.00M
FY201929 Dec 20193.54B+6.30%2.47B1.00B
FY201831 Dec 20183.33B+21.11%2.30B826.00M
FY201731 Dec 20172.75B+14.74%1.83B726.00M
FY201631 Dec 20162.40B+8.05%1.67B462.65M
FY201531 Dec 20152.22B+19.25%1.55B461.56M
FY201431 Dec 20141.86B+30.97%1.30B353.35M
FY201331 Dec 20131.42B+23.74%911.89M125.31M
FY201231 Dec 20121.15B+8.81%773.53M151.25M
FY201131 Dec 20111.06B+16.93%709.10M86.63M
FY201031 Dec 2010902.74M+35.48%601.54M124.89M
FY200931 Dec 2009666.32M+16.24%460.56M72.28M
FY200831 Dec 2008573.23M+56.28%367.60M50.48M
FY200731 Dec 2007366.80M+98.71%234.36M-278.36M
FY200631 Dec 2006184.59M+151.13%125.24M39.97M
FY200531 Dec 200573.50M+45.31%50.32M-20.87M
FY200431 Dec 200450.58M+80.43%37.32M-6.23M
FY200331 Dec 200328.04M+179.23%18.00M-27.06M
FY200231 Dec 200210.04M+303.86%6.50M-40.33M
FY200131 Dec 20012.49M+89.90%1.93M-24.82M
FY200031 Dec 20001.31M+176.17%1.71M-18.61M
FY199931 Dec 1999474.03K—570.39K-5.52M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Illumina revenue growth by segment

Q3 FY2026 against Q3 FY2025

Sequencing1.02B
+2.0%
Microarray108.00M
+30.1%

Illumina revenue by segment over time

Sequencing Microarray Core Illumina Consolidated Variable Interest Entities Product Consumables Instruments Other Products Services and Other Service, Other
Fiscal yearSequencingMicroarrayCore IlluminaConsolidated Variable Interest EntitiesProductConsumablesInstrumentsOther ProductsServices and OtherService, Other
FY20253.99B 358.00M — — — — — — — —
FY20234.11B -1.4%392.00M -5.1%— — — — — — — —
FY20224.17B +1.5%413.00M -1.0%— — — — — — — —
FY20214.11B 417.00M — — — — — — — —
FY2020— — — — 788.00M -1.7%— — — — 220.00M -8.3%
FY2019— — — — 802.00M -70.8%— — — — 240.00M
FY2018— — — — 2.75B 2.16B 569.00M 24.00M 584.00M —
FY2017— — 2.75B +13.4%6.00M — — — — — —
FY2016— — 2.43B 0.00 — — — — — —

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Illumina's revenue

Source: Financial Modeling Prep